Press Room

NASHVILLE, Tenn. – Gov. Bill Lee signed HB 2954/SB2883 this week, making Tennessee the sixth state in the U.S. to enhance coverage of prostate cancer screenings for high-risk men.

S. 689 & H. 1074 would ensure all communities benefit from the same advances in medical treatment through biomarker testing

ACS CAN released two reports today which provide a snapshot of utilization management requirements for specific cancer drugs in both the Medicare Part D plans and Medicare Advantage plans with drug coverage.

St. Paul, Minn.

PHILADELPHIA, PA—Yesterday, cancer patients and survivors gathered at the Philadelphia Hope Lodge to celebrate the forthcoming construction of an accessibility ramp to make the facility and gardens more accessible to guests.

SILVER SPRING, MD – The American Cancer Society Cancer Action Network (ACS CAN) called on U.S.

Today, the American Cancer Society Cancer Action Network, American Heart Association, American Lung Association and the Campaign for Tobacco-Free Kids issued the following statement:

Members of the newly formed Arizona Cancer Action Caucus held their inaugural meeting Wednesday afternoon at the state capitol to discuss ways to combat the disease in the state. The American Cancer Society Cancer Action Network (ACS CAN) helped form the caucus, which consists of a bipartisan group of seven state lawmakers. All members have been touched by cancer, including some who are survivors.

For the second year in a row, legislation to increase access to biomarker testing has failed to pass in the final days of legislative activity.

Federal legislation that would make it easier for all cancer patients to participate in clinical trials was introduced today in the House. Sponsored by Reps. Raul Ruiz (D-Calif.) and Larry Bucshon (R-Ind.), the Clinical Trial Modernization Act is bipartisan legislation that would increase access to clinical trials by helping remove cost and geographic barriers to patient participation.